Immunova is exercising a call option to acquire iOx Therapeutics Limited, a wholly owned AlphaTON subsidiary that develops cancer treatments.
Toncoin-focused treasury company AlphaTON agrees to sell cancer treatment subsidiary
1 month ago
25
- Homepage
- The Block Crypto
- Toncoin-focused treasury company AlphaTON agrees to sell cancer treatment subsidiary
Related
Cipher Digital adds third AI lease, lines up $200 million cr...
26 minutes ago
8
Tom Lee’s Bitmine debuts MAVAN Ethereum staking platform, pl...
44 minutes ago
6
Coinbase pushes order book, perps and futures data onchain w...
55 minutes ago
6
Trending
Popular
Why DeepSnitch AI Is Getting Early Attention in AI Circles f...
19 hours ago
48
BlockDAG Traders Use Code FINALTRADE to Secure Early Trading...
21 hours ago
31
Why Ripple (XRP) And Stellar (XLM) Are The Future Of Finance...
21 hours ago
29
DeepSnitch AI Price Prediction: DSNT Surges 205% While TAO a...
21 hours ago
27
RIV Coin Launches on Solana to Bridge Institutional Capital ...
23 hours ago
26
© CoinDesk 2026. All rights are reserved










English (US) ·